PATENT CLAIM ANALYSIS

Application Number: 16170344
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "168100"]

Abstract:
Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Claim (Index 18):
The pharmaceutical composition of  claim 16 , wherein the bacterial strains are human commensal bacteria.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 97.0
- Lexical Diversity: 1.21951
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14362097', '16160004', '15487553', '15019068', '15964285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.912799874523999
- 35 USC 102 Novelty (BERT): 0.7885362604537087
- Combined Prediction Score: 0.9003735131169701
- Mean Citation Score: 1147.21884
- Max Citation Score: 1272.8943
- Similarity Product: 988.8538359099268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test